ADHD Pharmacotherapy: An Update on Treatment Strategies and Clinical Considerations

CAN-eng

$0

gratuit

Mainpro+

30 min

Mental Health

0.5 Credits

APPRENDRE ENCORE PLUS

Description du cours

ADHD is a complex neurodevelopmental disorder that requires individualized treatment to improve patient outcomes. This program aims to support clinicians in optimizing ADHD management by reviewing current guideline-based treatment recommendations, strategies for medication selection and switching, key differences between ADHD drug formulations, and practical considerations when treating individuals with ADHD.  

Course Features: 

– 2 Ask the Expert videos, 
– 1 downloadable resource.  

Content Covered: 

Module: An Update on Treatment Strategies and Clinical Considerations

This program has received financial support from Sun Pharma Canada Inc. in the form of an unrestricted educational grant. 

Détails du cours

Date d'expiration : 2027-06-26
Métiers: Médecin

Faculté

  • Christine Palmay, MD, CCFP, FCFP
  • Jeffrey Habert, MD, CCFP, FCFP
  • Atul Khullar, MD MSc FRCPC FAASM DABPN

Accréditation

This activity meets the certification criteria of the College of Family Physicians of Canada and the Quebec College of Family Physicians, a continuing professional development accrediting organization recognized by the Collège des médecins du Québec and has been approved for up to 0.5 Mainpro+® Certified Activity credit(s). 
CERT+ Session ID: 303874-001

Objectifs d'apprentissage

Upon completion of this continuing education program, participants will be better able to:​

  • Reconnaître the signs and symptoms of ADHD to be able to accurately make a diagnosis. 
  • Apply guideline-based pharmacologic treatment for ADHD, including initiation and optimization of stimulant therapy.
  • Individualize treatment using non-stimulant options and stimulant formulation strategies.